Search Results for buy viagra online portugal๐ŸŽ๐ŸŒƒ www.ZavaMed.shop ๐ŸŒƒ๐ŸŽ cheap generic viagra online

TTA’s May Flowers 3: Venrock’s health biz predictions; Boots for sale; Oracle Health’s struggles; acquisitions by Samsung, Legrand; TytoCare, Owlet, Humana, more!

    A TON of news this week breaking before the US Memorial Day and UK’s bank holiday. Boots up for sale breaking up Alliance. Oracle Health will be struggling for the next two years. Cue Health sinking. Legrand is acquiring Enovation, Samsung Sonio ultrasound, and LG jumps into home health. And big VC Venrock issues its predictions for the health tech year. Short takes 2: Humana’s CEO changeover; Owlet Dream Sock CE Mark, UK approval; TytoCare goes to school; LG enters home health with Primefocus; Samsung $92M buys Sonio (FR); raises by Blackwell in health cybersec, Watershed Health News... Continue Reading

News roundup: GE Healthcare warns on ultrasound vulnerabilities, Geisinger leverages Best Buy/Geek Squad for RPM, telehealth aids NYC shelter homeless, Fay raises $25M, ClearDATA’s AWS distinction, Validic’s MedTech award

...devices 1) not be left unattended and 2) block incoming connections to workstations that have the clinical software installed and are connected to unprotected networks. Healthcare Dive Geisinger partners on patient monitoring with healthcare devices delivered by Best Buy/Geek Squad. For the past two years, Geisinger Health, now part of Risant Health, has been using Geek Squad to deliver and activate remote patient monitoring (RPM) devices such as blood-pressure cuffs, weight scales, thermometers, and glucose meters for those in active care management. The results of early pilots are: 50% faster time to activation of devices, 19% higher rate of patient... Continue Reading

Is Oracle Health’s Big Vision smacking into the wall of Healthcare Reality? Their business says so.

...taxpayers.” pointing to the OIG report issued in March. The contract is up for renewal this coming Thursday 16 May. NextGov, Becker’s The final burden on Oracle–only alluded to in the article–is the debt load undertaken to finance the $28 billion Cerner acquisition. A complex set of bridge and term loans were used to finance the buy [TTA 27 Oct 2022]. At the time, Oracle’s $90 billion debt load was one of the largest in tech. While Oracle’s stock value has been buoyed by their investments in AI, in the current environment, this debt load becomes suspect. Yahoo Finance, Quartz... Continue Reading

TTA’s May Flowers 2: ‘Not for sale’ Transcarent’s $2.2B valuation, good earnings from NeueHealth and Oscar (!!), Amwell’s hopes, cyberattacks at Ascension and DocGo, telehealth extensions in House, more!

...spring for funding, but there’s continued bad weather forecast for UnitedHealth Group and Oracle Cerner’s VA implementation. Facing Future 2: Walgreens writes down $5.8B for VillageMD in Q2, lowers 2024 earnings on ‘challenging’ retail outlook (Biting bullet early and hard) Short takes: PocketHealth, Brightside fundings; VA OIG reports hit Oracle Cerner; Change cyberattack/legal updates; UHG-Amedisys reviewed in Oregon; Optum to buy Steward Health practices (UHG carries on as does company funding) Can digital health RPM achieve meaningful change with type 2 diabetics? New metastudy expresses doubt. (Major digital health findings from PHTI) Have a job to fill? Seeking a position?... Continue Reading

TTA’s May Flowers: Walmart Health and Optum telehealth exits, UHG CEO’s Congressional roast, Teladoc’s red ink, Oracle’s Music City HQ move, MobileHelp PERS for sale, fundings, more!

...Facing Future 2: Walgreens writes down $5.8B for VillageMD in Q2, lowers 2024 earnings on ‘challenging’ retail outlook (Biting bullet early and hard) Short takes: PocketHealth, Brightside fundings; VA OIG reports hit Oracle Cerner; Change cyberattack/legal updates; UHG-Amedisys reviewed in Oregon; Optum to buy Steward Health practices (UHG carries on as does company funding) Can digital health RPM achieve meaningful change with type 2 diabetics? New metastudy expresses doubt. (Major digital health findings from PHTI) This week’s Big Quake was DOJ’s antitrust suit against Apple for smartphone monopoly and control over apps. Another quake: 2023 data breaches were up 187%–when... Continue Reading

News roundup: UHG CEO’s Bad Day at Capitol Hill; Kaiser’s 13.4M data breach; Walgreens’ stock beatup; Cigna writes off VillageMD; Oracle Cerner shrinks 50%; Owlet BabySat gets Wheel; fundings for Midi, Trovo, Alaffia, Klineo

...Citrix remote access without multi-factor authentication (MFA) was utterly savaged. According to Mr. Witty, ALPHV after days of knocking around got in on the one server that did not have MFA authentication. The blunt fact is that UHG had close to two years (January 2021-Oct 2022) before the buy closed. Due diligence consisting of a full audit had to have been done on Change’s IT systems. They processed what UHG wanted to buy. In this Editor’s estimation, Job #1! for UHG should have been ensuring that Change’s systems were hardened, then upgrading to what Mr. Witty called UnitedHealth’s standards. This... Continue Reading

TTA’s April Showers 4: UHG admits ransom payment–to whom? Interpreting Merger Guidelines misery, VA needs EHR testing help, DHA a ‘front door’; Lumeris’ funding, Optum layoffs, more!

...efficacy of present digital health diabetes solutions but provides solid direction forward. And it’s definitely an early sunny spring for funding, but there’s continued bad weather forecast for UnitedHealth Group and Oracle Cerner’s VA implementation. Facing Future 2: Walgreens writes down $5.8B for VillageMD in Q2, lowers 2024 earnings on ‘challenging’ retail outlook (Biting bullet early and hard) Short takes: PocketHealth, Brightside fundings; VA OIG reports hit Oracle Cerner; Change cyberattack/legal updates; UHG-Amedisys reviewed in Oregon; Optum to buy Steward Health practices (UHG carries on as does company funding) Can digital health RPM achieve meaningful change with type 2 diabetics?... Continue Reading

What the DOJ and FTC Merger Guidelines mean for healthcare M&A–review of the Epstein Becker Green podcast

Are you in the (mostly) lucky group of companies seeking to buy or be bought? This podcast is a ‘must hear’ as likely you’ll be affected. Healthcare law firm Epstein Becker Green’s roundtable podcast in the ‘Diagnosing Health Care’ series is their half-hour condensed view on the new Federal Merger Guidelines that the Department of Justice (DOJ) and the Federal Trade Commission (FTC) finalized last 18 December. Their view on how it will affect healthcare organizations is not too different from your Editor’s lengthy review of the DOJ/FTC document published on 20 December. The DOJ/FTC end-of-year drop perhaps (ahem) was... Continue Reading

Who really has the 4TB of Change Healthcare data 4 sale? And in great timing, Optum lays off a rumored 20K–say wot?

The data is for sale! And the top does not go down, but the price definitely goes up! That old antique auto auction cry is paraphrased here because the 4TB of patient data hacked from Change’s systems is up for sale, since Change/Optum didn’t buy it. Interested parties should stroll over to the dark web and see RansomHub’s listing for details. Unlike some news sources that got confused, this apparently is the same 4TB that BlackCat/ALPHV affiliate ‘notchy’ stole (technically, exfiltrated) posted about on a dark web site shortly after the attack [TTA 7 Mar]. According to those early reports,... Continue Reading

Weekend reading: 23andMe’s exploding plastic inevitable fate–and what might have been

23andMe may go private, break up, or go bankrupt. Not many other options. A major end-of-week news item in healthcare was that 23andMe, the beleaguered genetic testing company, may be taken private by its CEO and founder Anne Wojcicki per an SEC 8-K filing on 18 April and a press release issued the same day. Currently, she is a major shareholder controlling more than 20% of the total outstanding shares with ‘supervoting’ rights that entitle her to approximately 49% voting power. She filed a Schedule 13D the prior day indicating her intent to buy all outstanding shares. No offer value... Continue Reading